SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-016115
Filing Date
2022-04-27
Accepted
2022-04-27 09:07:18
Documents
6
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20003593x2_def14a.htm DEF 14A 482364
2 logo_ocuphire.jpg GRAPHIC 60098
3 logo_ocuphirex1.jpg GRAPHIC 75522
4 ny20003593x2_pc1.jpg GRAPHIC 614935
5 ny20003593x2_pc2.jpg GRAPHIC 463099
6 sig_msooch.jpg GRAPHIC 21844
  Complete submission text file 0001140361-22-016115.txt   2184103
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34079 | Film No.: 22856628
SIC: 2834 Pharmaceutical Preparations